InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Puromycin | FOXP1 drives osteosarcoma development by repressing P21 and RB transcription ... | 2021 | Oncogene | Li H. et al. | DOI: 10.1038/s41388-021-01742-4 |
2'3'-c-di-AM(PS)2 (Rp,Rp) VacciGrade™ | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
ADU-S100 | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
2'3'-cGAMP Control | Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potent... | 2021 | Front Oncol. | Esteves A.M. | DOI: 10.3389/fonc.2021.621550 |
PMA - Phorbol myristate acetate | Ex vivo characterization of Breg cells in patients with chronic Chagas disease. | 2021 | Sci Rep. | Girard M.C. et al. | DOI: 10.1038/s41598-021-84765-x |
C12-iE-DAP | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
C14-Tri-LAN-Gly | NOD1 Agonist Protects Against Lipopolysaccharide and D-Galactosamine-Induced ... | 2021 | Front Immunol. | Jia F. et al. | DOI: 10.3389/fimmu.2021.603192 |
Blasticidin | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
Zeocin® | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
QUANTI-Blue™ | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
IFN-α/β Reporter HEK 293 Cells | S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) ... | 2021 | J Transl Autoimmun | Duguet F. et al. | DOI: 10.1016/j.jtauto.2021.100093 |
HEK-Blue™ Selection | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
THP1-HMGB1-Lucia™ Cells | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
QUANTI-Luc™: Luciferase Detection Reagent | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
LPS-B5 (LPS from E. coli O55:B5) | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
QUANTI-Blue™ | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
Pam3CSK4 | GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern... | 2021 | PLoS One. | Pulsipher A. et al. | DOI: 10.1371/journal.pone.0249343 |
3'3'-cGAMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |
c-di-GMP | The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the... | 2021 | Nat Immunol. | Takahashi M. et al. | DOI: 10.1038/s41590-021-00896-3 |